- ►diabetesjournals.org A Goel, H Chiu, J Felton, JP Palmer, B Brooks … - Diabetes, 2007 - Am Diabetes Assoc Latent autoimmune diabetes in adults or type 1.5 diabetes is considered to be a
T-cell–mediated autoimmune disease. However, identification of patients is
based commonly on autoantibody (Ab) detection. To determine whether ... Cited by 5 - Related articles - BL Direct - All 6 versions
- ►ufjf.br [PDF] B Brooks-Worrell, A Warsen, JP Palmer - Journal of Immunological Methods, 2009 - Elsevier Diabetes mellitus is comprised primarily of two clinically separate diseases:
type 1 (T1D) and type 2 diabetes (T2D). T1D is a cell-mediated autoimmune
disease directed against the beta cells and characterized by autoantibody ... Cited by 1 - Related articles - All 3 versions
- ►diabetesjournals.org C Tiberti, C Giordano, M Locatelli, E Bosi, GF … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—IA-2 (256–760) fragment was identified as the marker with the
highest sensitivity for detection of humoral IA-2 immunoreactivity in LADA
patients, identifying IA-2 autoantibodies in ∼30% of GAD antibody (GADA)- ... Cited by 6 - Related articles - BL Direct - All 4 versions
M Shioya, A Andoh, S Kakinoki, A Nishida, Y … - Pancreas, 2008 - journals.lww.com Objectives: Interleukin (IL) 22 is a recently identified T-cellYderived
cytokine. IL-22 binds at the cell surface to a heterodimer receptor complex
composed of IL-22 receptor (R) 1 and IL-10R2. In this study, we performed ... Related articles - BL Direct - All 2 versions
CD Agardh, KF Lynch, M Palmér, K Link, Å … - Diabetologia, 2009 - Springer Abstract Aims/hypothesis The aim of this study was to ascertain whether
treatment of GAD65 autoantibody (GADA)-posi- tive diabetic patients with
alum-formulated recombinant GAD65 (GAD-alum) is safe and does not ... Cited by 3 - Related articles - All 2 versions
A Mayer, N Fabien, MC Gutowski, V Dubois, L … - European Journal of Endocrinology, 2007 - EFES Results: We observed that 16 out of 50 (32%) UD patients demonstrated responsive
PBMCs, as opposed to 1 out of 23 (5%) age- and HLA-matched normal control
subjects, and 0 out of 23 classic T2D patients. Overall, 29 (58%) UD ... Cited by 1 - Related articles - BL Direct - All 8 versions
[CITATION] Bengtsson Boströ m K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, …
Z Yang, Z Zhou, X Li, G Huang, J Lin - Diabetes research and clinical practice, 2009 - Elsevier The newly developed insulin sensitizer-thiazolidinediones have the potential to
downregulate inflammation and autoimmune response. The objective of this study
was to observe the beneficial effects on β-cell function in the LADA ... Cited by 2 - Related articles - All 14 versions
